RESUMO
Haemophilus influenzae is a human respiratory pathogen and inhabits the human respiratory tract as its only niche. Despite this, the molecular mechanisms that allow H. influenzae to establish persistent infections of human epithelia are not well understood. Here, we have investigated how H. influenzae adapts to the host environment and triggers the host immune response using a human primary cell-based infection model that closely resembles human nasal epithelia (NHNE). Physiological assays combined with dualRNAseq revealed that NHNE from five healthy donors all responded to H. influenzae infection with an initial, 'unproductive' inflammatory response that included a strong hypoxia signature but did not produce pro-inflammatory cytokines. Subsequently, an apparent tolerance to large extracellular and intraepithelial burdens of H. influenzae developed, with NHNE transcriptional profiles resembling the pre-infection state. This occurred in parallel with the development of intraepithelial bacterial populations, and appears to involve interruption of NFκB signalling. This is the first time that large-scale, persistence-promoting immunomodulatory effects of H. influenzae during infection have been observed, and we were able to demonstrate that only infections with live, but not heat-killed H. influenzae led to immunomodulation and reduced expression of NFκB-controlled cytokines such as IL-1ß, IL-36γ and TNFα. Interestingly, NHNE were able to re-activate pro-inflammatory responses towards the end of the 14-day infection, resulting in release of IL-8 and TNFα. In addition to providing first molecular insights into mechanisms enabling persistence of H. influenzae in the host, our data further indicate the presence of infection stage-specific gene expression modules, highlighting fundamental similarities between immune responses in NHNE and canonical immune cells, which merit further investigation.
Assuntos
Células Epiteliais , Infecções por Haemophilus , Haemophilus influenzae , Humanos , Haemophilus influenzae/imunologia , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/microbiologia , Células Epiteliais/microbiologia , Células Epiteliais/imunologia , Células Epiteliais/metabolismo , Mucosa Nasal/microbiologia , Mucosa Nasal/imunologia , Mucosa Nasal/metabolismo , Tolerância Imunológica , Células Cultivadas , Citocinas/metabolismoRESUMO
Biofilm formation has been suggested to be associated with phenotype changes compared with the planktonic form. We screened 1092 Haemophilus influenzae isolates for their genetic relationships and then selected 29 isolates from different genotypes and phenotypes and tested their ability to form biofilm. Our data showed a higher capacity of nontypable isolates, particularly isolates from respiratory and genital infections to form biofilm, compared with typable isolates. This ability to form biofilm was also correlated with reduced deposition of the complement component C3b on biofilm-involved bacteria. These data suggest that the biofilm formation contributes to the virulence of nontypable H. influenzae.
Assuntos
Biofilmes , Infecções por Haemophilus , Haemophilus influenzae , Haemophilus influenzae/genética , Haemophilus influenzae/fisiologia , Haemophilus influenzae/patogenicidade , Biofilmes/crescimento & desenvolvimento , Humanos , Infecções por Haemophilus/microbiologia , Infecções por Haemophilus/imunologia , Proteínas do Sistema Complemento/imunologia , Genótipo , Virulência , FenótipoRESUMO
Immunoglobulin A1 (IgA1) protease is a critical virulence factor of Haemophilus influenzae that facilitates bacterial mucosal infection. This study investigates the effect of iga gene polymorphism on the enzymatic activity of H. influenzae IgA1 protease. The IgA1 protease activity was examined in the H. influenzae Rd KW20 strain and 51 isolates. Genetic variations in iga and deduced amino acid substitutions affecting IgA1 protease activity were assessed. Machine learning tools and functional complementation assays were used to analyze the effects of identified substitutions on the stability and activity of IgA1 protease, respectively. All 51 isolates exhibited similar iga expression levels. No igaB expression was detected. According to comparisons with the reference Rd KW20 strain, four substitutions in the protease domain, 26 in the nonprotease passenger domain, and two in the ß-barrel domain were associated with the change in IgA1 protease activity. No substitutions in the catalytic site of IgA1 protease were observed. Logistic regression, receiver operating characteristic curves, Venn diagrams, and protein stability analyses revealed that the substitutions Asn352Lys, Pro353Ala, Lys356Asn, Gln916Lys, and Gly917Ser, which were located in the nonactive site of the passenger domain, were associated with decreases in IgA1 protease activity and stability, whereas Asn914Lys was associated with an increase in these events. Functional complementation assays revealed that the Asn914Lys substitution increased IgA1 protease activity in the Rd KW20 strain. This study identified substitutions in the nonactive site of the passenger domain that affect both the activity and stability of H. influenzae IgA1 protease.
Assuntos
Haemophilus influenzae , Haemophilus influenzae/genética , Haemophilus influenzae/enzimologia , Humanos , Substituição de Aminoácidos , Serina Endopeptidases/genética , Serina Endopeptidases/metabolismo , Serina Endopeptidases/química , Imunoglobulina A/metabolismo , Infecções por Haemophilus/microbiologia , Infecções por Haemophilus/imunologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Proteínas de Bactérias/químicaRESUMO
QseC is a membrane sensor kinase that enables bacteria to perceive autoinducers -3, adrenaline, and norepinephrine to initiate downstream gene transcription. In this study, we found that the QseC protein of Glaesserella parasuis can serve as an effective antigen to activate the host's immune response. Therefore, we investigated the immunogenicity and host protective effect of this protein. ELISA and indirect immunofluorescence results showed that QseC protein can induce high titer levels of humoral immunity in mice and regularly generate specific serum antibodies. We used MTS reagents to detect lymphocyte proliferation levels and found that QseC protein can cause splenic lymphocyte proliferation with memory and specificity. Further immunological analysis of the spleen cell supernatant revealed significant upregulation of levels of IL-1ß, IL-4 and IFN-γ in the QseC + adjuvant group. In the mouse challenge experiment, it was found that QseC + adjuvant can provide effective protection. The results of this study demonstrate that QseC protein provides effective protection in a mouse model and has the potential to serve as a candidate antigen for a novel subunit vaccine for further research.
Assuntos
Anticorpos Antibacterianos , Infecções por Haemophilus , Interferon gama , Interleucina-4 , Animais , Camundongos , Interleucina-4/metabolismo , Interleucina-4/imunologia , Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/imunologia , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/prevenção & controle , Infecções por Haemophilus/microbiologia , Interferon gama/metabolismo , Histidina Quinase/genética , Histidina Quinase/metabolismo , Histidina Quinase/imunologia , Interleucina-1beta/metabolismo , Interleucina-1beta/genética , Imunidade Humoral , Camundongos Endogâmicos BALB C , Baço/imunologia , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/genética , Proliferação de Células , Feminino , Adjuvantes Imunológicos , Haemophilus parasuis/imunologia , Haemophilus parasuis/genética , Citocinas/metabolismo , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/genética , Modelos Animais de Doenças , Antígenos de Bactérias/imunologia , Antígenos de Bactérias/genética , Linfócitos/imunologia , Vacinas de Subunidades Antigênicas/imunologia , Vacinas de Subunidades Antigênicas/genéticaRESUMO
Glaesserella parasuis is usually a benign swine commensal in the upper respiratory tract, but virulent strains can cause systemic infection characterized by pneumonia, meningitis, and fibrinous polyserositis. The intensive pulmonary inflammatory response following G. parasuis infection is the main cause of lung injury and death in pigs. Vaccination has failed to control the disease due to the lack of extended cross-protection. Accumulating evidence indicates that the heme-binding protein A (HbpA) is a potential virulence determinant and a promising antigen candidate for the development of a broader range of vaccines. However, it is not yet known whether HbpA contributes to G. parasuis virulence or has any potential immune protective effects against G. parasuis. Here, we show that HbpA can induce the transcription and secretion of proinflammatory cytokines (IL-6, TNF-α, and MCP-1) in porcine alveolar macrophages (PAM, 3D4/31). The HbpA protein is recognized by Toll-like receptors 2 and 4 on 3D4/21 macrophages, resulting in the activation of MAP kinase and NF-κB signalling cascades and the transcription and secretion of proinflammatory cytokines. HbpA contributes to virulence and bacterial pulmonary colonization in C57BL/6 mice and plays a role in adhesion to host cells and evasion of the bactericidal effect of pulmonary macrophages. In addition, mice immunized with HbpA were partially protected against challenge by G. parasuis SC1401. The results suggest that HbpA plays an important role in the pathogenesis of disease caused by G. parasuis and lay a foundation for the development of a subunit or chimeric anti-G. parasuis vaccine.
Assuntos
Infecções por Haemophilus , Haemophilus parasuis , NF-kappa B , Transdução de Sinais , Doenças dos Suínos , Animais , Camundongos , Haemophilus parasuis/imunologia , Infecções por Haemophilus/veterinária , Infecções por Haemophilus/prevenção & controle , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/microbiologia , NF-kappa B/metabolismo , Doenças dos Suínos/prevenção & controle , Doenças dos Suínos/microbiologia , Doenças dos Suínos/imunologia , Suínos , Proteínas de Bactérias/metabolismo , Proteínas de Bactérias/genética , Pasteurellaceae/imunologia , Inflamação/prevenção & controle , Inflamação/veterinária , FemininoRESUMO
Haemophilus parainfluenzae is a Gram-negative opportunist pathogen within the mucus of the nose and mouth without significant symptoms and has an ability to cause various infections ranging from ear, eye, and sinus to pneumonia. A concerning development is the increasing resistance of H. parainfluenzae to beta-lactam antibiotics, with the potential to cause dental infections or abscesses. The principal objective of this investigation is to utilize bioinformatics and immuno-informatic methodologies in the development of a candidate multi-epitope Vaccine. The investigation focuses on identifying potential epitopes for both B cells (B lymphocytes) and T cells (helper T lymphocytes and cytotoxic T lymphocytes) based on high non-toxic and non-allergenic characteristics. The selection process involves identifying human leukocyte antigen alleles demonstrating strong associations with recognized antigenic and overlapping epitopes. Notably, the chosen alleles aim to provide coverage for 90% of the global population. Multi-epitope constructs were designed by using suitable linker sequences. To enhance the immunological potential, an adjuvant sequence was incorporated using the EAAAK linker. The final vaccine construct, comprising 344 amino acids, was achieved after the addition of adjuvants and linkers. This multi-epitope Vaccine demonstrates notable antigenicity and possesses favorable physiochemical characteristics. The three-dimensional conformation underwent modeling and refinement, validated through in-silico methods. Additionally, a protein-protein molecular docking analysis was conducted to predict effective binding poses between the multi-epitope Vaccine and the Toll-like receptor 4 protein. The Molecular Dynamics (MD) investigation of the docked TLR4-vaccine complex demonstrated consistent stability over the simulation period, primarily attributed to electrostatic energy. The docked complex displayed minimal deformation and enhanced rigidity in the motion of residues during the dynamic simulation. Furthermore, codon translational optimization and computational cloning was performed to ensure the reliability and proper expression of the multi-Epitope Vaccine. It is crucial to emphasize that despite these computational validations, experimental research in the laboratory is imperative to demonstrate the immunogenicity and protective efficacy of the developed vaccine. This would involve practical assessments to ascertain the real-world effectiveness of the multi-epitope Vaccine.
Assuntos
Biologia Computacional , Epitopos de Linfócito B , Epitopos de Linfócito T , Humanos , Epitopos de Linfócito T/imunologia , Biologia Computacional/métodos , Epitopos de Linfócito B/imunologia , Simulação de Acoplamento Molecular , Infecções por Haemophilus/prevenção & controle , Infecções por Haemophilus/imunologia , Receptor 4 Toll-Like/imunologia , Receptor 4 Toll-Like/metabolismo , Receptor 4 Toll-Like/química , Desenvolvimento de VacinasRESUMO
Glaesserella parasuis is an important porcine pathogen that commonly colonizes the upper respiratory tract of pigs and is prone to causing Glässer's disease under complex conditions. As yet, the disease has led to serious economic losses to the swine industry worldwide. Studies so far have found that several virulence factors are associated with the pathogenicity of G. parasuis, but the pathogenic mechanism is still not fully understood. Cytolethal distending toxin (CDT), a potential virulence factor in G. parasuis, is involved in cytotoxicity, serum resistance, adherence to and invasion of host cells in vitro. Here, to further investigate the pathogenic role of CDT during G. parasuis infection in vitro and in vivo, a double cdt1 and cdt2 deletion mutant (Δcdt1Δcdt2) without selectable marker was first generated in G. parasuis JS0135 strain by continuous natural transformations and replica plating. Morphological observation and lactate dehydrogenase assay showed that the Δcdt1Δcdt2 mutant was defective in cytotoxicity. Additionally, the Δcdt1Δcdt2 mutant was more susceptible to phagocytosis caused by 3D4/2 macrophages compared to the wild-type JS0135 strain. Moreover, by focusing on clinical signs, necropsy, bacterial recovery and pathological observation, we found that the deletion of cdt1 and cdt2 genes led to a significant attenuation of virulence in G. parasuis. Taken together, these findings suggest that as an important virulence factor, CDT can significantly affect the pathogenicity of G. parasuis.
Assuntos
Toxinas Bacterianas , Haemophilus parasuis , Fagocitose , Doenças dos Suínos , Animais , Suínos , Haemophilus parasuis/patogenicidade , Haemophilus parasuis/genética , Toxinas Bacterianas/genética , Toxinas Bacterianas/toxicidade , Toxinas Bacterianas/metabolismo , Doenças dos Suínos/microbiologia , Virulência , Infecções por Haemophilus/veterinária , Infecções por Haemophilus/microbiologia , Infecções por Haemophilus/imunologia , Fatores de Virulência/genética , Macrófagos/microbiologia , Linhagem CelularRESUMO
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory illness in older adults. A major cause of COPD-related morbidity and mortality is acute exacerbation of COPD (AECOPD). Bacteria in the lungs play a role in exacerbation development, and the most common pathogen is non-typeable Haemophilus influenzae (NTHi). A vaccine to prevent AECOPD containing NTHi surface antigens was tested in a clinical trial. This study measured IgG and IgA against NTHi vaccine antigens in sputum. Sputum samples from 40 COPD patients vaccinated with the NTHi vaccine were collected at baseline and 30 days after the second dose. IgG and IgA antibodies against the target antigens and albumin were analyzed in the sputum. We compared antibody signals before and after vaccination, analyzed correlation with disease severity and between sputum and serum samples, and assessed transudation. Antigen-specific IgG were absent before vaccination and present with high titers after vaccination. Antigen-specific IgA before and after vaccination were low but significantly different for two antigens. IgG correlated between sputum and serum, and between sputum and disease severity. Sputum albumin was higher in patients with severe COPD than in those with moderate COPD, suggesting changes in transudation played a role. We demonstrated that immunization with the NTHi vaccine induces antigen-specific antibodies in sputum. The correlation between IgG from sputum and serum and the presence of albumin in the sputum of severe COPD patients suggested transudation of antibodies from the serum to the lungs, although local IgG production could not be excluded.Clinical Trial Registration: NCT02075541.
What is the context? Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory illness in older adults and the third leading cause of death worldwide.One bacterium in the lungs, non-typeable Haemophilus influenzae (NTHi), is responsible for acute exacerbation of the disease, characterized by an increase in airway wall inflammation and symptoms, leading to high morbidity and mortality.A vaccine targeting NTHi was previously developed but did not show efficacy in reducing exacerbations in COPD patients, probably because the vaccine did not elicit an immune response in the lung mucosae, where the bacteria are located.What is the impact? Parenteral immunization with new vaccines targeting NTHi is able to elicit immune defense at the level of lung mucosae.Now that antibodies can be measured in sputum, new vaccines against COPD exacerbations or other lung infections can be tested for efficacy in the actual target tissue.Also, lung immunity against specific pathogens can now be tested.What is new? We determined that antigen-specific antibodies were present in the lungs after vaccination; these were assessed in sputum after vaccination with NTHi surface antigens.NTHi-specific IgG were present in the lungs and appeared to have arrived there primarily by transudation, a type of leakage from the serum to the lung mucosae.Transudation appeared to be stronger in severe than in moderate COPD patients.
Assuntos
Anticorpos Antibacterianos , Antígenos de Bactérias , Infecções por Haemophilus , Vacinas Anti-Haemophilus , Haemophilus influenzae , Imunidade nas Mucosas , Imunoglobulina A , Imunoglobulina G , Doença Pulmonar Obstrutiva Crônica , Escarro , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/imunologia , Antígenos de Bactérias/imunologia , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/prevenção & controle , Haemophilus influenzae/imunologia , Vacinas Anti-Haemophilus/imunologia , Vacinas Anti-Haemophilus/administração & dosagem , Imunidade nas Mucosas/imunologia , Imunoglobulina A/imunologia , Imunoglobulina A/análise , Imunoglobulina A/sangue , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Pulmão/imunologia , Doença Pulmonar Obstrutiva Crônica/imunologia , Escarro/imunologia , Escarro/microbiologiaRESUMO
Infection with Glaesserella parasuis, the primary pathogen behind Glässer's disease, is often associated with diverse clinical symptoms, including serofibrinous polyserositis, arthritis, and meningitis. Autophagy plays a dual role in bacterial infections, exerting either antagonistic or synergistic effects depending on the nature of the pathogen. Our previous studies have demonstrated that autophagy serves as a defense mechanism, combating inflammation and invasion caused by infection of highly virulent G. parasuis. However, the precise mechanisms remain to be elucidated. Pathogens exhibit distinct interactions with inflammasomes and autophagy processes. Herein, we explored the effect of autophagy on inflammasomes during G. parasuis infection. We found that G. parasuis infection triggers NLRP3-dependent pro-CASP-1-IL-18/IL-1ß processing and maturation pathway, resulting in increased release of IL-1ß and IL-18. Inhibition of autophagy enhances NLRP3 inflammasome activity, whereas stimulation of autophagy restricts it during G. parasuis infection. Furthermore, assembled NLRP3 inflammasomes undergo ubiquitination and recruit the autophagic adaptor, p62, facilitating their sequestration into autophagosomes during G. parasuis infection. These results suggest that the induction of autophagy mitigates inflammation by eliminating overactive NLRP3 inflammasomes during G. parasuis infection. Our research uncovers a mechanism whereby G. parasuis infection initiates inflammatory responses by promoting the assembly of the NLRP3 inflammasomes and activating NLRP3-CASP-1, both of which processes are downregulated by autophagy. This suggests that pharmacological manipulation of autophagy could be a promising approach to modulate G. parasuis-induced inflammatory responses.
Assuntos
Autofagia , Caspase 1 , Infecções por Haemophilus , Haemophilus parasuis , Inflamassomos , Proteína 3 que Contém Domínio de Pirina da Família NLR , Animais , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/genética , Inflamassomos/imunologia , Inflamassomos/metabolismo , Haemophilus parasuis/imunologia , Haemophilus parasuis/patogenicidade , Haemophilus parasuis/genética , Caspase 1/metabolismo , Caspase 1/genética , Infecções por Haemophilus/veterinária , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/microbiologia , Suínos , Interleucina-18/metabolismo , Interleucina-18/genética , Interleucina-1beta/metabolismo , Interleucina-1beta/genética , Doenças dos Suínos/microbiologia , Doenças dos Suínos/imunologia , CamundongosRESUMO
MicroRNAs (miRNAs) have been shown to play an important regulatory role in the process of pathogenic infection. However, the miRNAs that regulate the pathogenic process of G. parasuis and their functions are still unknown. Here, high-throughput sequencing was used to quantify the expression of miRNA in piglet lung tissue after G. parasuis XX0306 strain infection. A total of 25 differentially expressed microRNAs (DEmiRNAs) were identified. GO and KEGG pathway enrichment analysis showed that many of the functions of genes that may be regulated by DEmiRNA are related to inflammatory response and immune regulation. Further studies found that ssc-miR-135 may promote the expression of inflammatory factors through NF-κB signaling pathway. Whereas, ssc-miR-155-3p inhibited the inflammatory response induced by G. parasuis, and its regulatory mechanism remains to be further investigated. This study provides a valuable reference for revealing the regulatory effects of miRNAs on the pathogenesis of G. parasuis. DATA AVAILABILITY: The datasets generated during the current study are not publicly available due to this study is currently in the ongoing research stage, and some of the data cannot be made public sooner yet, but are available from the corresponding author on reasonable request.
Assuntos
Infecções por Haemophilus , Haemophilus parasuis , Inflamação , Pulmão , MicroRNAs , Doenças dos Suínos , Animais , MicroRNAs/genética , Suínos , Pulmão/microbiologia , Pulmão/imunologia , Doenças dos Suínos/microbiologia , Doenças dos Suínos/genética , Doenças dos Suínos/imunologia , Inflamação/genética , Haemophilus parasuis/genética , Haemophilus parasuis/patogenicidade , Infecções por Haemophilus/veterinária , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/microbiologia , Infecções por Haemophilus/genética , Perfilação da Expressão Gênica , NF-kappa B/metabolismo , NF-kappa B/genética , Transdução de Sinais , Sequenciamento de Nucleotídeos em Larga Escala , Regulação da Expressão Gênica , Transcriptoma , Metastrongyloidea/genéticaRESUMO
OBJECTIVES: 17ß-estradiol (E2) is a steroidal hormone with immunomodulatory functions that play a role in infectious and inflammatory diseases. E2 was recently identified as the leading upstream regulator of differentially expressed genes in a comparative RNA sequencing study of pediatric patients with otitis media (OM) versus OM-free counterparts and may therefore play a role in the inflammatory response to bacterial otopathogens during pediatric OM. This study examined the effect of E2 on bacterial-induced inflammatory cytokine expression in an in vitro pediatric OM model. METHODS: An immortalized middle ear (ME) epithelial cell line, ROM-SV40, was developed from a pediatric recurrent OM patient. The culture was exposed to E2 at physiological levels for 1-48 h prior to 6 h-stimulation with nontypeable Haemophilus influenzae (NTHi) whole cell lysate. TNFA, IL1B, IL6, and IL8 were assayed by qPCR and ELISA. RESULTS: E2 pretreatment (24 h) abrogated NTHi induction of IL6; a longer pretreatment (1-10 nM, 48 h) abrogated IL1B induction (p < 0.05). E2 pretreatment (5 nM, 48 h) abrogated NTHi-induced IL8 secretion (p = 0.017). CONCLUSION: E2 pretreatment partially rescued NTHi-induced cytokine production by ME epithelia. These data support a role for E2 in moderating the excessive inflammatory response to middle ear infection that contributes to OM pathophysiology. LEVELS OF EVIDENCE: NA Laryngoscope, 134:3815-3819, 2024.
Assuntos
Citocinas , Orelha Média , Estradiol , Haemophilus influenzae , Otite Média , Humanos , Haemophilus influenzae/efeitos dos fármacos , Estradiol/farmacologia , Otite Média/microbiologia , Otite Média/imunologia , Otite Média/tratamento farmacológico , Orelha Média/microbiologia , Orelha Média/efeitos dos fármacos , Citocinas/metabolismo , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/tratamento farmacológico , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Criança , Linhagem Celular , InflamaçãoRESUMO
Thailand has incorporated the whole-cell (wP) pertussis vaccine into the expanded program on immunization since 1977 and has offered the acellular pertussis (aP) vaccine as an optional vaccine for infants since 2001. We followed healthy children from a clinical trial (ClinicalTrials.gov NCT02408926) in which children were randomly assigned to receive either pentavalent (DTwP-HB-Hib) or hexavalent (DTaP-IPV-HB-Hib) vaccines for their primary series (administered at 2, 4, and 6 months) and first booster vaccination (18 months). Both groups received Tdap-IPV as a second booster at the age of 4 y. Blood samples were collected for evaluation of antibody persistence to diphtheria toxoid (DT), tetanus toxoid (TT), and Bordetella pertussis (B. pertussis) between 2 and 6 y of age annually, and for the immunogenicity study of Tdap-IPV at 1 month after the second booster. Antibody persistence to Haemophilus influenzae type b (Hib) was followed until 3 y of age. A total of 105 hexavalent-vaccinated children and 91 pentavalent-vaccinated children completed this study. Both pentavalent and hexavalent groups demonstrated increased antibody levels against DT, TT, and B. pertussis antigens following the second booster with Tdap-IPV. All children achieved a seroprotective concentration for anti-DT and anti-TT IgG at 1 month post booster. The hexavalent group possessed significantly higher anti-pertactin IgG (adjusted p = .023), whereas the pentavalent group possessed significantly higher anti-pertussis toxin IgG (adjusted p < .001) after the second booster. Despite declining levels post-second booster, a greater number of children sustained protective levels of anti-DT and anti-TT IgG compared to those after the first booster.
Assuntos
Anticorpos Antibacterianos , Bordetella pertussis , Vacina contra Difteria, Tétano e Coqueluche , Vacinas Anti-Haemophilus , Haemophilus influenzae tipo b , Imunização Secundária , Vacinas Combinadas , Coqueluche , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Anticorpos Antibacterianos/sangue , Bordetella pertussis/imunologia , Difteria/prevenção & controle , Difteria/imunologia , Toxoide Diftérico/imunologia , Toxoide Diftérico/administração & dosagem , Vacinas contra Difteria, Tétano e Coqueluche Acelular/imunologia , Vacinas contra Difteria, Tétano e Coqueluche Acelular/administração & dosagem , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Vacina contra Difteria, Tétano e Coqueluche/administração & dosagem , Infecções por Haemophilus/prevenção & controle , Infecções por Haemophilus/imunologia , Haemophilus influenzae tipo b/imunologia , Vacinas Anti-Haemophilus/imunologia , Vacinas Anti-Haemophilus/administração & dosagem , Vacina Antipólio de Vírus Inativado/imunologia , Vacina Antipólio de Vírus Inativado/administração & dosagem , Toxoide Tetânico/imunologia , Toxoide Tetânico/administração & dosagem , Tailândia , Vacinas Combinadas/imunologia , Vacinas Combinadas/administração & dosagem , Coqueluche/prevenção & controle , Coqueluche/imunologia , SeguimentosRESUMO
Since the introduction of Haemophilus Influenzae type b (Hib) conjugate vaccines, invasive Hib disease has strongly declined worldwide, yet continued control of Hib disease remains important. In Europe, currently three different hexavalent combination vaccines containing Hib conjugates are marketed. In this phase IV, single-blind, randomized, controlled, multi-country study (NCT04535037), we aimed to compare, in a 2 + 1 vaccination schedule, the immunogenicity and safety and show non-inferiority, as well as superiority, of DTPa-HBV-IPV/Hib (Ih group) versus DTaP5-HB-IPV-Hib (Va group) in terms of anti-polyribosylribitol phosphate (PRP) antibody geometric mean concentrations (GMCs) and proportion of participants reaching anti-PRP antibody concentrations greater than or equal to a threshold of 5 µg/mL. One month after the booster vaccination, the anti-PRP antibody GMC ratio (Ih group/Va group) was 0.917 (95% CI: 0.710-1.185), meeting the non-inferiority criteria. The difference in percentage of participants (Ih group - Va group) reaching GMCs ≥5 µg/mL was -6.3% (95% CI: -14.1% to 1.5%), not reaching the predefined non-inferiority threshold. Interestingly, a slightly higher post-booster antibody avidity was observed in the Ih group versus the Va group. Both vaccines were well tolerated, and no safety concerns were raised. This study illustrates the different kinetics of the anti-PRP antibody response post-primary and post-booster using the two vaccines containing different Hib conjugates and indicates a potential differential impact of concomitant vaccinations on the anti-PRP responses. The clinical implications of these differences should be further studied.
Vaccination against Haemophilus influenzae type b (Hib) is included in the majority of national immunization programs worldwide and has shown to be effective in preventing Hib disease. In Europe, different vaccines containing Hib components are marketed. We compared the immune response and safety of 2 of these (DTPa-HBV-IPV/Hib, Ih group) and DTaP5-HB-IPV-Hib, Va group) in infants and toddlers, when used in a 2 + 1 schedule, i.e. two primary vaccination doses (at 2 and 4 months of age of the infant), followed by one booster dose at the age of one year. One month after the booster vaccination, the antibody concentration ratio between both groups (Ih group/Va group) was 0.917 (95% CI: 0.7101.185) showing the DTPa-HBV-IPV/Hib vaccine was non-inferior to the DTaP5-HB-IPV-Hib vaccine; the difference in percentage of participants (Ih group Va group) with antibody concentrations above 5 µg/mL was -6.3% (95% CI: −14.1% to 1.5%), which did not meet the pre-defined criterion for non-inferiority. In the Ih group, the quality of antibodies produced was somewhat higher versus the Va group. Both vaccines were well tolerated, and no safety concerns were raised. The kinetics of the immune response are different between the 2 vaccines. Since both vaccines contain different additional components (conjugated proteins), a possible effect of concomitant (simultaneously administered) vaccines was studied. Further investigations to confirm our findings are needed.
Assuntos
Anticorpos Antibacterianos , Vacinas Anti-Haemophilus , Haemophilus influenzae tipo b , Esquemas de Imunização , Polissacarídeos , Vacinas Combinadas , Vacinas Conjugadas , Humanos , Vacinas Anti-Haemophilus/imunologia , Vacinas Anti-Haemophilus/efeitos adversos , Vacinas Anti-Haemophilus/administração & dosagem , Anticorpos Antibacterianos/sangue , Lactente , Feminino , Masculino , Método Simples-Cego , Vacinas Conjugadas/imunologia , Vacinas Conjugadas/administração & dosagem , Vacinas Conjugadas/efeitos adversos , Haemophilus influenzae tipo b/imunologia , Vacinas Combinadas/imunologia , Vacinas Combinadas/administração & dosagem , Vacinas Combinadas/efeitos adversos , Infecções por Haemophilus/prevenção & controle , Infecções por Haemophilus/imunologia , Vacinas contra Hepatite B/imunologia , Vacinas contra Hepatite B/administração & dosagem , Vacinas contra Hepatite B/efeitos adversos , Vacina Antipólio de Vírus Inativado/imunologia , Vacina Antipólio de Vírus Inativado/administração & dosagem , Vacina Antipólio de Vírus Inativado/efeitos adversos , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Vacina contra Difteria, Tétano e Coqueluche/administração & dosagem , Vacina contra Difteria, Tétano e Coqueluche/efeitos adversos , Pré-Escolar , Imunogenicidade da Vacina , Europa (Continente)RESUMO
The Brazilian Purpuric Fever (BPF) is a systemic disease with many clinical features of meningococcal sepsis and is usually preceded by purulent conjunctivitis. The illness is caused by Haemophilus influenza biogroup aegyptius, which was associated exclusively with conjunctivitis. In this work construction of the las gene, hypothetically responsible for this virulence, were fusioned with ermAM cassette in Neisseria meningitidis virulent strains and had its DNA transfer to non BPF H. influenzae strains. The effect of the las transfer was capable to increase the cytokines TNFα and IL10 expression in Hec-1B cells line infected with these transformed mutants (in eight log scale of folding change RNA expression). This is the first molecular study involving the las transfer to search an elucidation of the pathogenic factors by horizontal intergeneric transfer from meningococci to H. influenzae.
Assuntos
Humanos , Citocinas/biossíntese , Células Epiteliais/imunologia , Células Epiteliais/microbiologia , Infecções por Haemophilus/imunologia , Haemophilus influenzae/imunologia , Fatores de Virulência/imunologia , Brasil , Linhagem Celular , Clonagem Molecular , Infecções por Haemophilus/microbiologia , Infecções por Haemophilus/patologia , Haemophilus influenzae/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Transformação Bacteriana , Fatores de Virulência/genéticaRESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Linfoma não Hodgkin/complicações , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/imunologia , Pneumonia Pneumocócica/epidemiologia , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/prevenção & controle , Vacinação/instrumentação , Vacinação/métodos , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/prevenção & controle , Haemophilus influenzae/isolamento & purificaçãoRESUMO
OBJETIVO: Identificar as evidências sobre o impacto da vacina conjugada para Haemophilus influenzae tipo b (Hib) na epidemiologia da doença invasiva por Hib. FONTE DOS DADOS: Pesquisa nas bases de dados do MEDLINE, LILACS, publicações técnicas de organizações internacionais, diretrizes nacionais e internacionais, nos últimos 15 anos (1991-2005), utilizando os seguintes unitermos: Haemophilus influenzae type b, immunization, impact, effectiveness. Foram incluídas as publicações que apresentaram informação para atender o objetivo deste artigo. Artigos publicados em período anterior ao da pesquisa e citados em referências dos artigos incluídos foram analisados quanto à apresentação de informação de interesse. SíNTESE DOS DADOS: A introdução da vacina conjugada para Hib produziu grande declínio na incidência de casos de doença invasiva por Hib nos diversos países em que seu uso foi incorporado à rotina de vacinação das crianças. No entanto, o ressurgimento de casos com doença invasiva por Hib tem mobilizado vários investigadores na busca das possíveis explicações para esses eventos, bem como a identificação das medidas a serem implementadas para evitar o reaparecimento da doença. CONCLUSÕES: O uso da vacina conjugada para Hib em escala populacional tem sido extremamente efetivo. No entanto, mudanças no esquema vacinal poderão ser necessárias para a manutenção do controle da doença invasiva por Hib, frente ao atual cenário epidemiológico das infecções pelo Hib.
Assuntos
Humanos , Infecções por Haemophilus/prevenção & controle , Vacinas Anti-Haemophilus/uso terapêutico , Haemophilus influenzae tipo b/imunologia , Programas de Imunização , Polissacarídeos Bacterianos/uso terapêutico , Vacinação , Saúde Global , Infecções por Haemophilus/complicações , Infecções por Haemophilus/imunologia , Vacinas Anti-Haemophilus/imunologia , Esquemas de Imunização , Programas de Imunização/estatística & dados numéricos , Meningite por Haemophilus/microbiologia , Polissacarídeos Bacterianos/imunologia , Fatores de Tempo , Vacinas Combinadas , Vacinas Conjugadas , Vacinação/normas , Vacinação/estatística & dados numéricosRESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Esplenomegalia/complicações , Esplenomegalia/diagnóstico , Esplenomegalia/cirurgia , Hiperesplenismo/complicações , Hiperesplenismo/diagnóstico , Esplenectomia/métodos , Laparotomia/métodos , Laparotomia/tendências , Esplenomegalia/fisiopatologia , Esplenomegalia , Streptococcus pneumoniae/imunologia , Streptococcus pneumoniae/isolamento & purificação , Infecções por Haemophilus/imunologia , Haemophilus influenzae/imunologia , Vacinas Anti-Haemophilus/uso terapêutico , Abdome/patologia , Abdome/cirurgia , AbdomeRESUMO
Day care centers are a relatively new phenomenon in Brazil that bring together large numbers of young children susceptible to contagious diseases. Haemophilus influenzae (Hi) is an important infection in the age range of those attending day care centers. In the present study, the carriage rate of haemophilus influenzae was identified in 38 day care attendees age 6 to 37 months, and 23 staff members, at a day care center in Ribeirao Preto - Sao Paulo, in 1997. To identify the carriers, two nasopharyngeal swabs were collected; one in july and one in december. The rate of H. influenzae carriers among the children was 77 percent. Only 2 of 23 staff members (9 percent) had Hi. Among the children, there were 58 isolates in the two sampling periods; 6 of the Hi were serotype b, 1 was serotype e, and 48 isolates were non-typeable. Two were identified as H. parainfluenzae. One adult had a non-typeable Hi and 1 had H. paraphrohaemolyticus. Three of the 6 children with type B had received a conjugate vaccine against H. influenzae type b, but they still carried this bacterium in the nasopharynx (50 percent). Forty ribotype patterns were found among the isolates, showing a high exchange rate of nontypeable H. influenzae carriers. The results indicate that, because of the high and changing biotype of Hi carriage, day care centers should be carefully monitored as potential point source of Hi disease in the community.
Assuntos
Humanos , Lactente , Pré-Escolar , Hospital Dia , Vacinas Bacterianas , Haemophilus influenzae , Infecções por Haemophilus/imunologia , Nasofaringe , Brasil , Estudos EpidemiológicosRESUMO
Background There is an urgent call for combined vaccines, containing multiple antigens, to ensure compliance by physicians and parents with the increasing number of vaccines recommended for children. To address this need, GlaxoSmithKline (GSK) Biologicals has developed a range of acellular pertussis-based diphtheria, tetanus, pertussis (DTPa) combination vaccines, the cornerstone of which is Infanrix (DTPa-GSK). These combination vaccines allow for flexibility and variations in schedules and recommendations in different countries. GSK's hexavalent vaccine (DTPa-HBV-IPV/Hib) covers six main diseases against which vaccination is recommended in many countries: diphtheria, tetanus, pertussis, hepatitis B, polio and Haemophilus influenzae type b. Clinical development In extensive clinical trials, the hexavalent GSK vaccine was well-tolerated and induced protective antibody levels against diphtheria, tetanus, hepatitis B and polio. Decreased levels of antibody against H. influenzae type b were not considered clinically relevant mainly because they were compensated for by the induction of immune memory. The three pertussis antigens (PT, FHA and PRN) produced levels of antibodies that were equivalent to those specifically generated in efficacy trials with DTPa-GSK vaccine. Further support for the protective capacity of the hexavalent vaccine against pertussis came from mouse model data and post-marketing effectiveness studies. Conclusions This manuscript provides an overview of the clinical characteristics, immunogenicity, efficacy and reactogenicity of the hexavalent GSK vaccine. The safety and effectiveness of this combination will permit vaccination against six diseases with single injections, minimize the distress to infants and children, improve cost-effectiveness, and extend vaccine coverage. In addition, the hexavalent combination lends itself as the vaccine of choice for parents and healthcare providers for childhood vaccination schedules (AU)
No disponible
Assuntos
Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Vacinas Combinadas/imunologia , Vacina contra Coqueluche/imunologia , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Vacinas contra Difteria, Tétano e Coqueluche Acelular/economia , Vacinas contra Difteria, Tétano e Coqueluche Acelular/imunologia , Hepatite B/imunologia , Haemophilus influenzae/imunologia , Vacinas Anti-Haemophilus/imunologia , Proteção da Criança/legislação & jurisprudência , Poliomielite/imunologia , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/prevenção & controleRESUMO
Background The introduction of polysaccharide-protein conjugate vaccines against Haemophilus influenzae type b (Hib) in the 1990's resulted in a dramatic reduction in the number of cases of invasive Hib disease. In Germany, following the launch of DTPa/Hib combination vaccines in late 1996 and DTPa-IPV/Hib in 1998, the majority of Hib immunisations are made with such combinations. It is well established that such combinations elicit lower anti-Hib antibody concentrations than the equivalent Hib conjugate administered as a separate injection. While there are good reasons to assume that this is of no clinical relevance the clinical impact of this phenomenon has not yet been fully evaluated. Methods and Findings To assess the impact of DTPa/Hib combination vaccines on the incidence of invasive Hib disease in Germany two independent, one hospital- and one laboratory-based, surveillance systems were used during 1998-99 for detection of cases. Tetra- and penta- valent DTPa-Hib vaccines accounted for 92.1 % of all Hib vaccines used in 1999. During the 2 year study period the annual number of invasive Haemophilus influenzae b disease decreased further from 28 in 1998 to 13 in 99. National vaccination coverage rates for 1998/99 revealed that only 70 % of children given DTPa/Hib or DTPa-IPV/Hib received the recommended 3 doses in their first year of life, the overall effectiveness of the most used combination vaccine was high at 97.4 % (95 % CI: 96.0-98.3) for those who had received at least one dose of such a vaccine. In subjects who received the full 3-dose schedule effectiveness was 98.8 % (95 % CI: 98.1-99.2). Conclusion These data show that the lower anti-Hib antibody concentrations observed with DTPa/Hib combination vaccines are of no clinical relevance (AU)
No disponible